96902 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used; Regulators; Modulating activity stimulating, promoting or activating activity
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#302Peptide exhibiting hair growth promoting activity and/or melanin production promoting activity and use thereof
#303Peptide having hair growth-promoting activity and/or melanin generation-promoting activity, and use thereof
#304Screening method
#305VEGF antagonist formulations suitable for intravitreal administration
#306Compositions and methods of using islet neogenesis peptides and analogs thereof
#307Stabilized BCL9 peptides for treatment of aberrant WNT signaling
#308Compositions and methods directed to treating liver fibrosis
#309CELL CULTURE PROCESS FOR MAKING A GLYCOPROTEIN
#310Method using expression of LIN28 for preparing stem cells having excellent renewal ability and therapeutic capacity
#311ATP-binding cassette family coding polyribonucleotides and formulations thereof
#312NKG2D decoys
#313TREATING CARDIOVASCULAR OR RENAL DISEASES
#314Methods and compositions for reducing the immunogenicity of chimeric notch receptors
#315MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF COSMETIC PROTEINS AND PEPTIDES
#316Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#317FOXM1-derived peptide, and vaccine including same
#318Leg1 Protein, Leg1 Gene, and Uses and Drugs thereof
#319Modified Polynucleotides for the production of biologics and proteins associated with human disease
#320MESSENGER RIBONUCLEIC ACIDS FOR ENHANCING IMMUNE RESPONSES AND METHODS OF USE THEREOF
#321Peptide compound
#322Cell lines for screening odorant and aroma receptors
#323Method for predicting risk of exposure to interstitial fibrosis and tubular atrophy with clusterin
#324High-throughput screening of regulatory element function with epigenome editing technologies
#325ERG targeted therapy
#326UROCORTIN 2 ANALOGS AND USES THEREOF
#327Methods for modulating development and function of photoreceptor cells
#328Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#329METHOD FOR GENERATING SOMATIC STEM CELLS
#330Cell-penetrating ATF5 polypeptides and uses thereof
#331FUSOGENIC PROPERTIES OF SAPOSIN C AND RELATED PROTEINS AND PEPTIDES FOR APPLICATION TO TRANSMEMBRANE DRUG DELIVERY SYSTEMS
#332Generation of human iPS cells by a synthetic self-replicative RNA
#333Methods and compositions for combination immunotherapy
#334Cancer specific-splicing ribozyme and use thereof
#335Modulation of BCL11A for treatment of hemoglobinopathies
#336CRISPR-based methods and products for increasing frataxin levels and uses thereof
#337Cell-based assay for determining mTOR activity
#338VEGF antagonist formulations suitable for intravitreal administration
#339COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES
#340METHODS FOR GENERATING ENDOGENOUSLY TAGGED PROTEINS
#341Therapeutic methods, products and compositions inhibiting ZNF555
#342LINGO-2 ANTAGONISTS FOR TREATMENT OF CONDITIONS INVOLVING MOTOR NEURONS
#343Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5
#344USE OF ENDOGENOUS PROMOTERS TO EXPRESS HETEROLOGOUS PROTEINS
#345Agent for prevention or treatement of corneal disorders
#346Targeting GIV-GEF-GI signaling for treating diverse diseases
#347Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same
#348USE OF CAR-MODIFIED HUMAN NATURAL KILLER CELLS TO TREAT CANCER
#349Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis
#350Peptide for inducing regeneration of tissue and use thereof
#351NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS
#352Method of treating vitiligo using mutant HSP70i
#353Methods and compositions for regenerating tissues
#354Genetically modified pig cells with an inactivated Etv2 gene
#355Fully-human T-cell receptor specific for the 369-377 epitope derived from the Her2/neu (ERBB2) receptor protein
#356Compositions and methods for custom site-specific DNA recombinases
#357Fatty acid modified urocortin-2 analogs for the treatment of diabetes and chronic kidney disease
#358COMPOSITIONS AND METHODS OF USING ISLET NEOGENESIS PEPTIDES AND ANALOGS THEREOF
#359Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5
#360Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
#361Methods for treating and preventing cardiomyopathy with a fusion protein of tafazzin and a cellular permeability peptide
#362Therapeutic effects of NURR1 and FOXA2 in inflammatory neurologic disorders by M1-to-M2 polarization of glial cells
#363In vivo production of proteins
#364Chloroplast Expressing Colostrum or Milk Polypeptides
#365Use of anti-semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastases
#366Engineering a heterogeneous tissue from pluripotent stem cells
#367PEPTIDOMIMETIC MACROCYCLES
#368Methods of lowering serum cholesterol
#369Production cell line enhancers
#370Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5
#371Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5
#372RTEF-1 VARIANTS AND USES THEREOF
#373Mannose-6-phosphate bearing peptides fused to lysosomal enzymes
#374Methods for treating cardiovascular dysfunction and improving fluid homeostasis with Elabela peptide hormone
#375PANCREATIC CANCER TARGETS AND USES THEREOF
#376Compositions and methods for treatment of muscular dystrophy
#377PEPTIDE-BASED STAT INHIBITOR
#378Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
#379Compositions and methods for increasing the expression and signalling of proteins on cell surfaces
#380Method for treating adenosine deaminase severe combined imunodeficiency
#381DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION
#382Modulation of BCL11A for treatment of hemoglobinopathies
#383COMPOSITIONS FOR THE TREATMENT OF WOUNDS
#384Transcription activator-like effectors
#385Methods and compositions for the packaging of nucleic acids into microglial exosomes for the targeted expression of polypeptides in neural cells
#386Mammalian cell lines expressing functional nematode acetylcholine receptors and use thereof for high-throughput screening assays
#387NUCLEIC ACID CONSTRUCTS ENCODING REPROGRAMMING FACTORS LINKED BY SELF-CLEAVING PEPTIDES
#388RNA-interference by single-stranded RNA molecules
#389Stitched polypeptides
#390Methods for treating myocardial infarction comprising administering sonic hedgehog
#391Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#392Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#393Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#394Peptides and combination of peptides for use in immunotherapy against non-small cell lung cancer and other cancers
#395Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#396Method for treating cancer with an activated T lymphocyte that selectively recognizes a cancer cell consisting of specific peptide
#397Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#398Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#399Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#400Method for generating immune cells resistant to arginine and/or tryptophan depleted microenvironment
#401Selective inhibitors of c-Fos and their antiproliferative properties
#402Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptor adapters
#403Compositions and methods of using islet neogenesis peptides and analogs thereof
#404Positive modulator of bone morphogenic protein-2
#405Colostrum/milk protein compositions
#406Norrin regulation of cellular production of junction proteins and use to treat retinal vasculature edema
#407Multiplex guide RNAs
#408Production cell line enhancers
#409Human leucine zipper/trail recombinant polypeptides
#410Chloroplast expressing colostrum or milk polypeptides
#411Method for removing genomically unstable IPS cells and synthetic peptide used therefor
#412Lipid co-factor essential for cell density signaling
#413VEGF antagonist formulations suitable for intravitreal administration
#414STABILIZED POLYPEPTIDES AND USES THEREOF
#415Artificial transcription factors comprising a sliding domain and uses thereof
#416PLIF multimeric peptides and uses thereof
#417VEGF antagonist formulations suitable for intravitreal administration
#418FUSOGENIC PROPERTIES OF SAPOSIN C AND RELATED PROTEINS AND PEPTIDES FOR APPLICATION TO TRANSMEMBRANE DRUG DELIVERY SYSTEMS
#419USE OF MULTIVALENT SYNTHETIC LIGANDS OF SURFACE NUCLEOLIN FOR TREATING CANCER OR INFLAMMATION
#420APPLICATIONS OF AN IMMUNE SYSTEM-RELEASED ACTIVATING AGENT (ISRAA)
#421RESEARCH BIO-NANOPARTICLE ELEMENTS AND PLATFORMS
#422Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
#423R-spondin variants, compositions, and methods of use
#424Reagents and methods for treating dental disease
#425Modified polynucleotides for the production of proteins
#426ANALOGS OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND METHODS FOR THEIR USE
#427VP16-CREB fusion gene
#428Use of antibodies or antigen-binding fragments thereof that specifically bind semaphorin-4D to increase tumor infiltrating leukocyte frequency
#429Methods for treating brain cancer using il-13r alpha 2 peptide-based compositions
#430Lung cancer biomarker
#431TARGETED MODULATION OF MACROPHAGES
#432PEPTIDOMIMETIC MACROCYCLES
#433METHODS OF DETERMINATION OF ACTIVATION OR INACTIVATION OF ATRIAL NATRIURETIC PEPTIDE (ANP) AND BRAIN NATRIURETIC PEPTIDE (BNP) HORMONAL SYSTEMS
#434Modified polynucleotides for the production of biologics and proteins associated with human disease
#435Modified T cell comprising a polynucleotide encoding an inducible stimulating molecule comprising MyD88, CD40 and FKBP12
#436COMPOSITIONS AND METHODS FOR INHIBITING TUMOR CELLS BY INHIBITING THE TRANSCRIPTION FACTOR ATF5
#437EIF4E binding peptides
#438Methods for modulating development and function of photoreceptor cells
#439In vivo production of proteins
#440Inducible Expression System Transcription Modulators Comprising A Distributed Protein Transduction Domain And Methods For Using The Same
#441Production cell line enhancers
#442Positive modulator of bone morphogenic protein-2
#443Methods for treating myocardial infarction comprising administering sonic hedgehog
#444Sequence of nucleotides and peptides GSE 24.2 of dyskerin, which can induce telomerase activity, method for obtaining same, therapeutic compositions and applications thereof
#445Urocortin 2 analogs and uses thereof
#446Materials and Methods for Regulating Whole Body Glucose Homeostasis
#447IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE
#448DOSAGE REGIME OF FUSION COMPOUNDS
#449BETA-CATENIN TARGETING PEPTIDES AND USES THEREOF
#450Small molecule polypeptide for inhibiting inflammation
#451Antagonist for (pro)renin receptor for the treatment of hypertension and diabetes
#452Hydrogen bond surrogate macrocycles as modulators of Ras
#453Method for regulating cell proliferation
#454TIF1-Gamma for Treating and Diagnosing Inflammatory Diseases
#455METHODS FOR THE TREATMENT AND PREVENTION OF OSTEOPOROSIS AND BONE-RELATED DISEASES
#456LAT adapter molecule for enhanced T-cell signaling and method of use
#457Production cell line enhancers
#458Controlled modulation of amino acid side chain length of peptide antigens
#459Modified polynucleotides for the production of cosmetic proteins and peptides
#460Generation of human iPS cells by a synthetic self-replicative RNA
#461Compositions which regulate the epithelial brush border Na/H exchanger NHE3 and their methods of use in gastrointestinal disease
#462Methods of treatment of cancer using SRC-modulating peptides
#463Acid-resistance in by engineering transcriptional factor
#464LINGO-2 antagonists for treatment of conditions involving motor neurons
#465Endothelial cell-specific polynucleotides and use thereof
#466Methods for delivery to the central nervous system of nucleic acid nanoparticles to treat central nervous system disorders
#467WNT7A compositions and method of using the same
#468Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptor adapters
#469Target molecules for transcriptional control systems
#470RNA-interference by single-stranded RNA molecules
#471Reagents and methods for treating dental disease
#472Modified polynucleotides for the production of proteins
#473RHOGEF12 IS A THERAPEUTIC TARGET FOR THE TREATMENT OF HEART FAILURE
#474Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis
#475TL1A model of inflammation fibrosis and autoimmunity
#476Treating cardiovascular or renal diseases
#477RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
#478Method for obtaining a dialyzable leukocyte extract
#479RTEF-1 variants and uses thereof
#480MUTANT HSP70i TO PREVENT AUTOIMMUNE DISEASE
#481MCPIP as wound therapy
#482SINGLE DOMAIN TDF-RELATED COMPOUNDS AND ANALOGS THEREOF
#483VEGF antagonist formulations for intravitreal administration
#484Engineering a heterogeneous tissue from pluripotent stem cells
#485Modified polynucleotides for treating protein deficiency
#486Screening method
#487Methods for enhancing genome stability and telomere elongation in embryonic stem cells
#488Commensal bacteria as singal mediators within a mammalian host
#489Modified polynucleotides for treating galactosylceramidase protein deficiency
#490Peptide for inducing regeneration of tissue and use thereof
#491Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders
#492Modified polynucleotides encoding basic helix-loop-helix family member E41
#493Compositions and methods for custom site-specific DNA recombinases
#494Modified polynucleotides encoding citeD4
#495ERAP1-derived peptide and use thereof
#496Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocator
#497MODIFIED POLYNUCLEOTIDES FOR TREATING CYSTIC FIBROSIS
#498Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders
#499Modified polynucleotides encoding septin-4
#500Modified polynucleotides encoding granulysin
#501Modified polynucleotides encoding apoptosis inducing factor 1
#502Modified polynucleotides encoding hepatitis A virus cellular receptor 2
#503Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1
#504Modified polynucleotides encoding aquaporin-5
#505Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptor adapters
#506Cell model and method for screening c-Fms kinase inhibitors
#507Synthetic peptide that induces expression of TNF receptor 2 and use thereof
#508Hydrogen bond surrogate macrocycles as modulators of Ras
#509Anti-aging peptides and cosmetic and/or pharmaceutical composition containing same
#510Establishment of motif comprising acidic amino acid, capable of stabilizing protein in cells, and applicable to protein therapy, control of differentiation/undifferentiation of cell and antibody therapy
#511Archease as RNA ligaes complex member
#512VEGF antagonist formulations for intravitreal administration
#513Modified polynucleotides for the production of biologics and proteins associated with human disease
#514Modified polynucleotides for the production of secreted proteins
#515Human interleukin-1 receptor antagonist—hybrid Fc fusion protein
#516Plant transactivation interaction motifs and uses thereof
#517Methods and compositions for the inhibition of Stat5 in prostate cancer cells
#518Compositions and methods of treating head and neck cancer
#519Compositions and methods directed to treating liver fibrosis
#520TREATMENT OF CARDIAC CONDITIONS
#521Na+/K+-ATPase-specific peptide inhibitors/activators of Src and Src family kinases
#522Regulatory proteins and inhibitors
#523B-cell stimulating fusion proteins of an antigen with BAFF or APRIL
#524Methods Relating to Mammalian Rictor Polypeptide
#525eIF4E binding peptides
#526Modulation of BCL11A for treatment of hemoglobinopathies
#527Tango 240 nucleic acids and uses thereof
#528Genes from 20q13 amplicon and their uses
#529USE OF ENDOGENOUS PROMOTERS TO EXPRESS HETEROLOGOUS PROTEINS
#530METHODS FOR GENERATING ENDOGENOUSLY TAGGED PROTEINS
#531BIOSENSORS COMPRISING PROTEIN-BINDING DOMAINS AND FLUORESCENT PROTEINS
#532Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#533METHOD FOR STABILIZATION OF PROTEINS USING NON-NATURAL AMINO ACIDS
#534Protein arginine N-methyltransferase-5 method of cancer treatment
#535Reporter system for high throughput screening of compounds and uses thereof
#536SYSTEMS AND METHODS FOR PROTEIN PRODUCTION
#537Methods and compositions for the inhibition of Stat5 in prostate cancer cells
#538METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
#539Solution Assay and High Through-Put Screen to Probe Interaction Between Human Cullin-Ring Ligase Complex and HIV-VIF Protein
#540Transcription activator-like effectors
#541RNA-INTERFERENCE BY SINGLE-STRANDED RNA MOLECULES
#542UROCORTIN 2 ANALOGS AND USES THEREOF
#543METHODS AND COMPOSITIONS FOR TREATING OCCULAR DISORDERS
#544Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#545Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same
#546Peptidomimetic macrocycles
#547T-Bet Compositions and Methods of Use Thereof
#548Methods for enhancing genome stability and telomere elongation in embryonic stem cells
#549Inhibitors of heat shock RNA
#550PHARMACEUTICAL COMPOSITION CONTAINING NUCLEAR FACTOR INVOLVED IN PROLIFERATION AND DIFFERENTIATION OF CENTRAL NEURONAL CELLS
#551Inducible expression system transcription modulators comprising a distributed protein transduction domain and methods for using the same
#552Pancreatic cancer targets and uses thereof
#553Isolation and growth of stem cells from hemangiomas
#554LAT adapter molecule for enhanced T-cell signaling and method of use
#555PROTEIN WITH PROMOTING EFFECTS FOR AXONAL GROWTH OF NEURONS OF CENTRAL NERVOUS SYSTEM
#556Pipemidic acid derivative autotaxin inhibitors
#557A PKN3/RHOC MACROMOLECULAR COMPLEX AND METHODS OF USE THEREFOR
#558PGC-1β, a novel PGC-1 homologue and uses therefor
#559METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
#560VEGF antagonist formulations for intravitreal administration
#561TL1A model of inflammation fibrosis and autoimmunity
#562RTEF-1 variants and uses thereof
#563INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES
#564TARGETING OF SALL4 FOR THE TREATMENT AND DIAGNOSIS OF PROLIFERATIVE DISORDERS ASSOCIATED WITH MYELODYSPLASTIC SYNDROME (MDS)
#565Nucleic acid constructs encoding reprogramming factors linked by self-cleaving peptides
#566POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME AND USE THEREOF IN THE TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH ISCHEMIA
#567Compositions to Treat Cardiac Pacing Conditions
#568MEANS AND METHOD FOR THE TREATMENT OF ANTIBODY DEFICIENCY DISEASES BASED ON IL-21 AND IL-21 VARIANTS
#569Protein Expression Methods
#570Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis
#571Systems and Methods to Treat Cardiac Pacing Conditions
#572Methods for treating cardiac pacing conditions
#573METHOD FOR MODULATING MUSCLE DIFFERENTIATION OR REGENERATION
#574Commensal bacteria as signal mediators within a mammalian host
#575NOVEL ANTI-AGING PEPTIDES AND COSMETIC AND/OR PHARMACEUTICAL COMPOSITION CONTAINING SAME
#576NURR-1 Interacting Protein (NuIP)
#577Nuclear factor κB inducing factor
#578VEGF antagonist formulations for intravitreal administration
#579Nuclear factor κB inducing factor
#580Senescene Cells and Methods For Its Production
#581PEPTIDE ANTAGONISTS OF ZONULIN AND METHODS FOR USE OF THE SAME
#582Modulation of BCL11A for treatment of hemoglobinopathies
#583TRANSCRIPTIONAL BIOMARKERS AND METHODS FOR DETECTING AND ISOLATING CANCER CELLS IN BODY FLUIDS AND TISSUE SPECIMENS
#584Snapin and methods for regulation of microtubule assembly and dendrite growth and branching
#585Prostate cancer-related compositions, methods and kits based on DNA microarray proteomics platforms
#586Nel-related type 1 polypeptide
#587Soluble notch-based substrates for gamma secretase and methods and compositions for using same
#588Methods of identifying compounds that bind TANGO240
#589Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation
#590DENDRITIC CELL POTENTIATION
#591Single domain TDF-related compounds and analogs thereof for use in treating a tissue differentiation factor related disorder
#592STAT3 EPITOPE PEPTIDES
#593SIVA 3, its preparation and use
#594Compositions and methods for inhibiting adipogenesis by inhibition of constitutive coactivator of ppargamma
#595Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#596Cottonwood Growth eIF-5A
#597TRANSGENIC PROTEINS FROM MULTI-GENE SYSTEMS, METHODS, COMPOSITIONS, USES AND THE LIKE RELATING THERETO
#598Methods for expressing proteins in axons
#599Methods for treating breast cancer using NRIF3 related molecules
#600POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME AND USE THEREOF IN THE TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH ISCHEMIA